Is there a case for a global COVID-19 Marshall Plan? / Sina Shokoohyar, George Sillup, J. Michael Riordan, Bob DeMento, James McTauge, and Charlie Evert.

Format:

Book

Author/Creator:

Shokoohyar, Sina, author.

Sillup, George, author.

Riordan, J. Michael, Esq., author.

DeMento, Bob, author.

McTague, James, author.

Evert, Charlie, author.

Series:

SAGE business cases.

SAGE business cases

Language:

English

Subjects (All):

Globalization--Economic aspects--Case studies.

Globalization.

COVID-19 Pandemic, 2020-2023--Economic aspects--Case studies.

COVID-19 Pandemic, 2020-2023.

Physical Description:

1 online resource : illustrations.

Place of Publication:

London : SAGE Publications: SAGE Business Cases Originals, 2023.

Summary:

This case study questions the disjointed responses and failures to mitigate the COVID-19 pandemic around the world. As a result of partial measures and inequality in access to vaccines, COVID-19 has continued to spread and mutate. Mutations have become more contagious and have reduced vaccine efficacy globally. After World War II, through the Marshall Plan and related programs around the world, the United States successfully distributed aid to rebuild economies and achieve humanitarian and national security objectives at a cost of about $170 billion in today's dollars. Vaccinating every eligible human on earth would likely be less expensive and could likewise achieve humanitarian, economic, and national security benefits. This case asks students to consider whether wealthy countries could and should create a global response like the Marshall Plan to vaccinate enough people to approach global herd immunity and what the incentives are for wealthy countries to fund such a plan.

Notes:

Description based on publisher supplied metadata and other sources.

ISBN:

1-0719-1246-1

9781071912461

OCLC:

1362531178